You’re using a public version of DrugPatentWatch with 5 free searches available | Register to unlock more free searches. CREATE FREE ACCOUNT

Last Updated: April 17, 2024

AVANDIA Drug Patent Profile


✉ Email this page to a colleague

« Back to Dashboard


Which patents cover Avandia, and when can generic versions of Avandia launch?

Avandia is a drug marketed by Woodward and is included in one NDA.

The generic ingredient in AVANDIA is rosiglitazone maleate. There are twelve drug master file entries for this compound. Additional details are available on the rosiglitazone maleate profile page.

Summary for AVANDIA
Drug patent expirations by year for AVANDIA
Drug Prices for AVANDIA

See drug prices for AVANDIA

Recent Clinical Trials for AVANDIA

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
Dan ZandbergPhase 2
University Health Network, TorontoN/A
Barcelona Institute for Global HealthN/A

See all AVANDIA clinical trials

US Patents and Regulatory Information for AVANDIA

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Woodward AVANDIA rosiglitazone maleate TABLET;ORAL 021071-002 May 25, 1999 DISCN Yes No ⤷  Try a Trial ⤷  Try a Trial ⤷  Try a Trial
Woodward AVANDIA rosiglitazone maleate TABLET;ORAL 021071-003 May 25, 1999 DISCN Yes No ⤷  Try a Trial ⤷  Try a Trial ⤷  Try a Trial
Woodward AVANDIA rosiglitazone maleate TABLET;ORAL 021071-004 May 25, 1999 DISCN Yes No ⤷  Try a Trial ⤷  Try a Trial ⤷  Try a Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Expired US Patents for AVANDIA

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Woodward AVANDIA rosiglitazone maleate TABLET;ORAL 021071-002 May 25, 1999 ⤷  Try a Trial ⤷  Try a Trial
Woodward AVANDIA rosiglitazone maleate TABLET;ORAL 021071-002 May 25, 1999 ⤷  Try a Trial ⤷  Try a Trial
Woodward AVANDIA rosiglitazone maleate TABLET;ORAL 021071-003 May 25, 1999 ⤷  Try a Trial ⤷  Try a Trial
Woodward AVANDIA rosiglitazone maleate TABLET;ORAL 021071-002 May 25, 1999 ⤷  Try a Trial ⤷  Try a Trial
Woodward AVANDIA rosiglitazone maleate TABLET;ORAL 021071-004 May 25, 1999 ⤷  Try a Trial ⤷  Try a Trial
Woodward AVANDIA rosiglitazone maleate TABLET;ORAL 021071-004 May 25, 1999 ⤷  Try a Trial ⤷  Try a Trial
Woodward AVANDIA rosiglitazone maleate TABLET;ORAL 021071-003 May 25, 1999 ⤷  Try a Trial ⤷  Try a Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >Patent No. >Patent Expiration

International Patents for AVANDIA

See the table below for patents covering AVANDIA around the world.

Country Patent Number Title Estimated Expiration
Japan 2837139 ⤷  Try a Trial
Japan H09183726 MEDICINE FOR TREATMENT AND PROPHYLAXIS OF TROUBLE AND DISORDER OF GLUCOSE TOLERANCE ⤷  Try a Trial
South Korea 100371297 ⤷  Try a Trial
Brazil 1100841 ⤷  Try a Trial
China 1152878 ⤷  Try a Trial
Japan 2828777 ⤷  Try a Trial
Greece 3030794 ⤷  Try a Trial
>Country >Patent Number >Title >Estimated Expiration

Supplementary Protection Certificates for AVANDIA

Patent Number Supplementary Protection Certificate SPC Country SPC Expiration SPC Description
0658161 C300035 Netherlands ⤷  Try a Trial PRODUCT: ROSIGLITAZONE,MALEAAT, DESGEWENST IN DE VORM VAN EEN FARMACEUTISCH AANVAARDBAAR SOLVAAT.
0306228 C300034 Netherlands ⤷  Try a Trial PRODUCT NAME: ROSIGLITAZONE, DESGEWENST IN DE VORM VAN EEN FARMACEUTISCH AANVAARDBAAR ZOUT EN/OF EEN FARMACEUTISCH AANVAARDBAAR SOLVAAT, IN HET BIJZONDER ROSIGLITAZONE MALEAAT; REGISTRATION NO/DATE: EU/1/00/137/001 - EU/1/00/137/012 20000711
0658161 39/2000 Austria ⤷  Try a Trial PRODUCT NAME: ROSIGLITAZONE MALEAT; NAT. REGISTRATION NO/DATE: EU/1/00/137/001 - EU/1/00/137/012 20000711; FIRST REGISTRATION: LI 55176 19990929
0306228 2001C/004 Belgium ⤷  Try a Trial PRODUCT NAME: ROSIGLITAZONE; REGISTRATION NO/DATE: EU/1/00/137/001 20000717
0658161 SPC001/2001 Ireland ⤷  Try a Trial SPC001/2001: 20050808, EXPIRES: 20140928
0658161 01C0002 France ⤷  Try a Trial PRODUCT NAME: MALEATE DE ROSIGLITAZONE OU L UN DE SES ISOMERES OU UNE DE SES FORMES TAUTOMERES ET/OU UN DE SES SOLVATES PHARMACEUTIQUEMENT ACCEPTABLES; REGISTRATION NO/DATE IN FRANCE: EU/1/00/137/001 DU 20000711; REGISTRATION NO/DATE AT EEC: IKS Nø 55 176 DU 19990929
0658161 SPC/GB01/003 United Kingdom ⤷  Try a Trial PRODUCT NAME: N-(4-(2(N-METHYL-N-(2-PYRIDYL)AMINO)ETHOXY)BENZYL)THIAZOLIDINE-2,4-DIONE MALEIC ACID, "ROSIGLITAZONE MALEATE", ITS TAUTOMERS AND PHARMACEUTICALLY ACCEPTABLE SOLVATES; REGISTERED: CH 55176 02 19990929; CH 55176 03 19990929; CH 55176 04 19990929; UK EU/1/00/137/001 20000711; UK EU/1/00/137/002 20000711; UK EU/1/00/137/003 20000711; UK EU/1/00/137/004 20000711; UK EU/1/00/137/005 20000711; UK EU/1/00/137/006 20000711; UK EU/1/00/137/007 20000711; UK EU/1/00/137/008 20000711; UK EU/1/00/137/009 20000711; UK EU/1/00/137/010 20000711; UK EU/1/00/137/011 20000711; UK EU/1/00/137/012 20000711
>Patent Number >Supplementary Protection Certificate >SPC Country >SPC Expiration >SPC Description

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.